Seasonal and gender-specific patterns in prescriptions for hypnotic and sedative medications in primary care
Open Access
- 20 May 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 17, 1785512
Abstract
Introduction: Population-level prevalence of sleep disorders can be assessed using prescription data for hypnotic and sedative medications. Such prescribing patterns exhibit seasonality that may be linked to variations in daylight exposure. The aim of this study was to analyze temporal trends in prescriptions for drugs with sedative-hypnotic properties. Methods: Prescription data for hypnotics and sedatives were analyzed retrospectively and stratified by month, year, and patient gender. Seasonal patterns, associations with day length, and the effects of transitions between daylight saving time and standard time were examined. Changes in prescription numbers during the COVID-19 pandemic were also assessed. Relative differences in prescription counts were evaluated using incidence rate ratios (IRR). Results: Prescription numbers were lowest in summer (May–August) and highest in winter and early spring. Increasing day length was significantly associated with reduced prescription rates. A decline in prescriptions occurred earlier and was more pronounced in men (February–September; IRR 0.88–0.95), whereas in women the changes were weaker and mainly limited to summer months (June–August; IRR 0.94–0.97), with a slight increase observed in February. During the COVID-19 pandemic, prescription numbers decreased significantly. Transitions between standard and daylight saving time exerted measurable short-term effects on sleep-related health at the population level. Conclusions: Based on data from a single primary care center in Poland, prescribing patterns for hypnotic and sedative medications demonstrate clear seasonality and significant gender differences. Longer daylight exposure and transitions to daylight saving time are associated with lower prescription rates. The COVID-19 pandemic substantially disrupted previous trends in sleep medication prescribing, which may be related to reduced access to healthcare services and changes in healthcare delivery. In addition, transitions between standard and daylight saving time were associated with statistically significant short-term changes in prescription rates.Keywords
This publication has 40 references indexed in Scilit:
- Alzheimer’s disease and sleep disorders: A bidirectional relationshipNeuroscience, 2024
- Factors associated with changes in sleep quality and use of sleep medications in beneficiaries of health plansSleep Epidemiology, 2023
- Sleep disturbances during the COVID-19 pandemic: A systematic review, meta-analysis, and meta-regressionSleep Medicine Reviews, 2022
- The effects of seasons and weather on sleep patterns measured through longitudinal multimodal sensingnpj Digital Medicine, 2021
- Delayed Sleep-Wake Phase Disorder2020
- Tracking Insomnia Seasonal Variations Through Consumption of HypnoticsEuropean Psychiatry, 2017
- Circadian disrupting exposures and breast cancer risk: a meta-analysisInternational Archives of Occupational and Environmental Health, 2014
- Regression Analysis of Count Data2013
- Chronic insomniaThe Lancet, 2012
- Negative Binomial Regression2011